18F-fluorodeoxyglucose-positron emission tomography:: A new explorative perspective

被引：27

作者：

Schirmer, M

Calamia, KT

Wenger, M

Klauser, A

Salvarani, C

Moncayo, R

机构：

[1] Univ Hosp, Dept Internal Med, A-6020 Innsbruck, Austria

[2] Mayo Clin, Div Rheumatol, Jacksonville, FL 32224 USA

[3] Univ Innsbruck Hosp, Dept Nucl Med, A-6020 Innsbruck, Austria

[4] Univ Innsbruck Hosp, Dept Radiol, A-6020 Innsbruck, Austria

[5] Div Rheumatol, Reggio Emilia, Italy

来源：

EXPERIMENTAL GERONTOLOGY | 2003年 / 38卷 / 04期

关键词：

imaging technique; radionuclide; inflammation; autoimmune disease; diagnosis;

D O I：

10.1016/S0531-5565(02)00267-X

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

F-18-Fluorodeoxyglucose-positron emission tomography (F-18-FDG-PET) is a new functional imaging technique available for clinical and experimental use. F-18-FDG-PET studies can be used for screening, localization and follow-up of hypermetabolic processes including malignancies, infections and autoimmune processes. For several years it has been applied in oncological, cardiological and neurological patients, but nowadays an increasing number of studies favours its use in patients with autoimmune diseases including large vessel arteritis. From the experimental view, this technique has even become more important since the introduction of a small PET scanner for the use in animal models. This review focuses on technical aspects, clinical experiences and experimental and future perspectives of F-18-FDG-PET, with a special emphasis on large vessel vasculitis and other autoimmune diseases. (C) 2003 Elsevier Science Inc. All rights reserved.

引用

页码：463 / 470

页数：8

共 58 条

[1] In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography [J].